20 June 2013
Keywords: mapreg, spinal, injury, drug, gets, od, status
Article | 24 March 2008
Mapreg, a French biotechnology company specialized in the development of novel drugs for the treatment of central nervous system diseases, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 March 2008
19 June 2013
© 2013 thepharmaletter.com